• ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study

    Nov 20, 2019, 08:28 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Nov 20, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has reached a significant milestone: Global biopharmaceutical companies have relied on ERT’s centralized cardiac safety solution to assess the safety of their new medical compounds in more than 10,000 clinical studies across all phases of clinical development
    Full story
  • Telepresence System To Be Tested In PTSD Trial

    Nov 20, 2019, 06:20 by Michael Croft

    Clinical Research News | A wearable technology platform could extend the value of telemedicine to the treatment of mental health disorders—notably, PTSD, which is alarmingly prevalent among veterans.

    Full story
  • CRISPR For Sickle Cell Disease Shows Promise In Early Test

    Nov 19, 2019, 15:29 by Michael Croft
    NPR.org |  Doctors are reporting the first evidence that genetically edited cells could offer a safe way to treat sickle cell disease, a devastating, incurable disorder that afflicts millions of people around the world.
    Full story
  • Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients

    Nov 18, 2019, 16:01 by Michael Croft
    HOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences’ Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection
    Full story
  • Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland

    Nov 18, 2019, 13:33 by Michael Croft
    KING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21
    Full story
  • Survey Findings Show Increase in Clinical Trial Results Transparency

    Nov 15, 2019, 11:48 by Michael Croft
    JERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) Survey
    Full story
  • Morality And Machines: How To Use AI Ethically For Drug Development

    Nov 15, 2019, 10:50 by Michael Croft

    Clinical Research News Contributed Commentary | AI can and has been seriously misused in several fields, including criminal justice where people have ended up wrongfully imprisoned thanks to AI, so it’s critical that life sciences organizations understand how to deploy AI without harming patients.

    Full story
  • Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration

    Nov 14, 2019, 12:05 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Nov 14, 2019 - Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraph’s CentrePoint system
    Full story
  • Guys and St Thomas' NHS Trust Finds 'Right Data, Right Place, Right Time' With Information Retrieval Architecture

    Nov 14, 2019, 09:15 by Michael Croft

    Clinical Research News | Guys and St Thomas' NHS Trust addresses the significance of the modern information economy using CogStack, the foundation's structured and unstructured information retrieval and extraction architecture.

    Full story
  • Full-Circle Study Start Up and Site Payments Activities for Successful Sites and Studies

    Nov 13, 2019, 08:05 by Michael Croft

    Clinical Research News Contributed Commentary | Clinical trial success hinges on the commitment of the participating investigators and their clinical staff, and their enthusiasm is highest at study start. Sponsors and contract research organizations must leverage technology, people and systems to fuel the sites’ excitement—and to keep them engaged through the study’s duration. Yet the clinical development industry has not mastered early and sustained site engagement.

    Full story
  • Syneos, AiCure Announce Strategic Partnership

    Nov 12, 2019, 16:05 by Michael Croft
    Clinical Research News Brief | Syneos Health and AiCure have announced a novel strategic partnership to drive faster, smarter trials to optimize patient engagement. The collaboration amplifies a pre-existing relationship and responds to increasing customer demand for digital solutions that change behaviors and improve patients’ lives.
    Full story
  • Google Partners With Major Health System Gaining Access To Patient Data

    Nov 12, 2019, 08:19 by Michael Croft
    STAT |  Google has quietly launched "Project Nightingale," an initiative that gives the tech giant the ability to analyze personal health information from Ascension, a Catholic hospital system.
    Full story
  • How Accurate Are Real World Data?

    Nov 11, 2019, 09:40 by Michael Croft

    Clinical Research News | The 21st Century Cures Act, passed in 2016, placed additional focus on real world data to support regulatory decision making, including new indications for approved drugs. In the legislation, Congress defined real world evidence as data regarding the usage or the potential benefits or risks of a drug derived from sources other than traditional clinical trials. But how do we know if these data are accurate?

    Full story
  • Industry Leaders Convene in New York for EXTRA: TrialScope Transparency Experience

    Nov 7, 2019, 16:29 by Michael Croft
    JERSEY CITY, NJ, UNITED STATES - Nov 7, 2019 - At the recent EXTRA: TrialScope Transparency Experience in New York City, TrialScope brought together pharmaceutical sponsors, patient advocacy organizations and other industry leaders for two days of presentations, workshops and networking
    Full story
  • Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology

    Nov 7, 2019, 11:43 by Michael Croft
    PHILADELPHIA, PA - Nov 7, 2019 - Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technology
    Full story
  • TrialAssure Launches Document Anonymization Software

    Nov 7, 2019, 10:10 by Michael Croft

    Clinical Research News Brief | TrialAssure today launched the limited release of ANONYMIZE R, a first-in-class document anonymization software that uses machine learning, natural language processing, and artificial intelligence to protect patient privacy by automatically finding and removing personal information from text.

    Full story
  • Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.

    Nov 7, 2019, 09:04 by Michael Croft
    PHILADELPHIA, PA - Nov 7, 2019 - Signant Health, formerly CRF Health and Bracket, announced today that it is sponsoring the Philadelphia Walk to End Alzheimer’s
    Full story
  • Standardizing eClinical Terminology: Easing the Site Burden to Improve Quality, Compliance and Safety

    Nov 5, 2019, 09:45 by Michael Croft

    Clinical Research News Contributed Commentary | As in years past, the clinical trial industry declared 2019 “The Year of the Patient.” However, the phrase “Year of the Patient” raises an important consideration about clinical trial terminology: a growing number of trial volunteers also prefer to be called “subject” because the meaning of “patient” can have different connotations for everyone.

    Full story
  • Clinical Trials Laboratory Services Shows Donor Appreciation with Enhanced Services at its Blood Donation Centers

    Nov 4, 2019, 08:37 by Michael Croft
    LONDON, UK - Nov 4, 2019 - Clinical Trials Laboratory Services (CTLS), a leading provider of human blood products and biological specimens to the research community, today announced that it has made several enhancements to the donor experience at its donor center in North West London, UK
    Full story
  • Shimmer Receives CE Certification for its ECGmd Holter Monitor Electrocardiograph

    Nov 4, 2019, 08:14 by Michael Croft
    CAMBRIDGE, MA - Nov 4, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that ECGmd – its five-wire, four-lead holter monitor electrocardiograph (ECG) – is now a CE certified, Class IIa medical device under the Medical Device Directive (93/42/EEC)
    Full story
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187 (current)
  • 188
  • 189
  • 190
  • »